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Measuring Ageing by a Handshake  
The Impact of Sarcopenia on Healthy Ageing  
Ingrid Knudsen Aas  
Abstract 
Sarcopenia, an age-related condition characterized by low levels of muscle mass, carries personal 
and financial costs. Understanding the condition and its consequences is essential to implement 
successful interventions for people with and people at risk of developing sarcopenia. Using data 
from SHARE of people aged 50 and older, the effect of sarcopenia on ageing is estimated. Results 
suggest that sarcopenia has a significant negative impact on ageing. Quantitatively, the effect of 
sarcopenia on the healthy ageing indices is equivalent to having aged approximately one decade. 
Through the estimation of a production function of sarcopenia, the importance of physical activity 
as prevention is confirmed.  
 
Keywords: sarcopenia, healthy ageing, Selfie Aging Index, Active Ageing Index 
 
1.   Introduction  
Ageing populations are among the greatest challenges of the 21st century. The European 
Commission (2017) projects the old-age dependency ratio to rise from 29.6% in 2016 to 51.2% 
in 2070, inter alia, due to increased life expectancy.2 This transition poses new challenges for the 
future. For instance, increased costs of health care and a diminishing work force are creating a 
need for governments to address age-related health problems and to promote healthy ageing.  
       This work project is motivated by the hypothesis that sarcopenia has a negative impact on 
healthy ageing. Reduced muscle mass is an expected consequence of ageing, and sarcopenia is an 
age-related condition characterized by substantial loss in muscle mass. It is a fairly new concept, 
and there is no consensus on the definition. The European Working Group on Sarcopenia in Older 
People (EWGSOP) (Cruz-Jentoft et al. 2010) defines sarcopenia as: “a syndrome characterized 
by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse 
outcomes such as physical disability, poor quality of life and death”. According to EWGSOP, 
sarcopenia leads to falls and fractures, admission to nursing homes, loss of independence and high 
cost of health care. With the anticipated ageing population, the prevalence of sarcopenia is 
expected to rise.3  
                                                
2 Old-age dependency ratio: people aged 65 or more relative to those aged 15 to 64.  
3 EWGSOP estimates a prevalence of sarcopenia worldwide of more than 200 million in the next 30 years. According 
to EWGSOP, more than 50 million people worldwide had sarcopenia in 2010. 
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            Results from this work project point towards sarcopenia having a negative impact on 
healthy ageing. The effect of sarcopenia on the healthy ageing indices is equivalent to 
approximately one decade of age increase, signalizing the importance and widespread 
consequences of the condition.                                                                                                                
            The work project is organized as follows: First, a literature review on the concept of 
healthy ageing, the Selfie Aging Index, the Active Ageing Index and a production function of 
sarcopenia is presented. Second, the methodologies used for the different approaches are 
described. Third, the results of the models are presented. Finally, limitations and concluding 
remarks with possible implications are discussed.  
2.   Literature Review  
Healthy ageing is an extensively used term, although there is no complete consensus on the 
definition. The World Health Organization (WHO, 2015) defines healthy ageing as “the process 
of developing and maintaining the functional ability that enables wellbeing in older age”. 
Functional ability captures an individual’s ability to “meet their basic needs, to learn, grow and 
make decisions, to be mobile, to build and maintain relationships and to contribute to society” 
(WHO 2015). The Healthy Ageing Project, carried out by the Swedish National Institute of Public 
Health (2007), defines healthy ageing as “the process of optimizing opportunities for physical, 
social and mental health to enable older people”.4 In practice, healthy ageing is about acquiring 
a healthy life style, working longer and having an active life after retirement. Healthy ageing is 
not a static concept, as functional abilities are expected to decline with age, life choices and other 
interventions (WHO 2015).5 Older people with an active lifestyle seem to be more motivated to 
participate socially, engage in healthy behaviors and have in general less problems dealing with 
difficulties (Paúl, Ribeiro, and Teixeira 2012). Optimizing the healthy ageing potential could 
potentially reduce health care costs.  
                                                
4 The Healthy Ageing Project is a project under the EU Public Health Programme aiming at promoting healthy ageing. 
The project was initiated by the Swedish National Institute of Public Health and is co-funded by the European 
Commission.	  
5 In 2002 WHO replaced the term “active ageing” with “healthy aging”. Some organizations may only refer to one 
of the concepts while others refer to both.  
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The Active Ageing Index (AAI) and the Selfie Aging Index (SAI) are two approaches 
used to measure healthy ageing. The effect of sarcopenia on healthy ageing can be measured using 
the two indices. The appliance of both methods may provide a more comprehensive notion of 
healthy ageing and add extra validity to the estimation results. Additionally, the usage of both 
proxies overcome the shortages of each method.6 
The SAI, developed by Gonçalves et al. (2017), is a multidimensional index based on self-
assessed health indicators allowing people to take a selfie of their ageing status. The index 
contains indicators of three domains: biological, psychological and social, and is based on the 
Biopsychosocial Assessment Model.7 The SAI uses self-assessed health as the dependent variable 
to establish the sources of each element of the index. Numerous papers point to self-assessed 
health as a good proxy for healthy ageing. For example, Pfarr, Schmid, and Schneider (2012) find 
self-assessed health to be a suitable predictor of the old-age health status.8  
The AAI is a tool created by United Nations Economic Commission for Europe (UNECE) 
and the European Commission (EC, 2015) to “measure the untapped potential of older people for 
active and healthy ageing across countries”. The index is a weighted average of four domains: 
(1) employment, (2) participation in society, (3) independent, healthy and secure living and (4) 
capacity and enabling for active ageing. Each domain, composed of different indicators, represent 
discrete features of active ageing.9 
Having presented the two indices that will be used to disclose if sarcopenia has an impact 
on healthy ageing, the focus is turned to the production function of sarcopenia. A production 
function may provide information on the relevant predictors of sarcopenia. Finding relevant 
factors may also help identifying intervention strategies. The production function is based on the 
well-known Grossman model (Grossman 1972), which establishes the relation between health 
                                                
6 Critique of the individual level AAI points to some of the indicators not being appropriate on the individual level. 
For example, being employed (1st domain: Employment) may not be relevant to analyse the respondent’s perception 
of active ageing. Additionally, the individual level AAI do not exploit the full variation of the data because they are 
dichotomized (Gonçalves et al. 2017). 
7 The Biopsychosocial Assessment Model was first proposed by Engel (1977) whose main aim was to develop a 
model that captured the biological, psychological and social aspect of the individuals health.  
8 Self-assessed health has also been found to be a good predictor of mortality (Mossey and Shapiro 1982).	  
9 The domains and corresponding weights are decided by a group of experts based on political relevance. The experts 
consist of academics, statisticians and representatives from international organisations such as OECD, EC and 
UNECE.	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and different health inputs. This paper applies a simple production function approach in which 
sarcopenia is replacing health as the dependent variable. To obtain suitable explanatory variables, 
existing, but limited literature on sarcopenia is reviewed. Among the inputs of the production 
function of sarcopenia are physical activity, income and body mass index. 
Physical activity could reduce the likelihood of developing sarcopenia. Sarcopenia is 
found to be preventable by early intervention through nutrition and physical activity (Martone et 
al. 2015; Yu et al. 2016). Ryu et al. (2013) also finds, after adjusting for covariates, that Koreans 
older than 65 years doing physical activity are less likely to have sarcopenia.  
Income is also included in the production function. People with higher income are found 
to do more exercise (Downward 2007). Considering that existing literature points at physical 
activity being preventive of sarcopenia, it is of interest to check if income plays a role on the 
likelihood of developing sarcopenia.  
The relation between body mass and sarcopenia is frequently mentioned in the literature, 
in particular, sarcopenia co-occurring with either a high or low body mass index (BMI). High 
BMI in older age, with increased risk of obesity and heart trouble, can increase the risk of 
sarcopenia (Ryu et al. 2013). Low BMI can be a sign of poor nutrition and little food intake, which 
in turn again can lead to loss of muscle mass and sarcopenia (Muscaritoli et al. 2010).  
According to EWGSOP, sarcopenia is related to older age, poor life quality and 
admissions to nursing homes. All the aforementioned factors will be included to test if the 
relations found in existing literature hold for the SHARE sample.  
3.   Methodology  
3.1 Data  
To measure the impact of sarcopenia on healthy ageing, data from the Survey of Health, Ageing 
and Retirement in Europe (SHARE) is used. The dataset consists of data from six waves on health 
and socio-economic factors for Europeans aged 50 years and older.10 SHARE contains data on 
handgrip strength which can be used to define sarcopenia. To measure the grip strength, 
respondents were asked to push as hard as they possibly could on a dynamometer while standing 
                                                
10 SHARE (collected from 2004-2015) was constructed to be representative for Europeans over 50.  
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up. Respondents with sarcopenia are identified using EWGSOP´s definition of sarcopenia; grip 
strength lower than 30 kg for men and 20 kg for women. Due to biological differences, men and 
women have different cut-off values, hence each gender is analyzed separately. The variable of 
interest, sarcopenia, is a dummy variable taking value 1 if the individual has sarcopenia and 0 
otherwise. A selection of descriptive statistics is presented in Table I. Approximately 13% of the 
total sample have sarcopenia, 15.8% of all women and 9.8% of all men, respectively.11  
Table I. Descriptive Statistics 
	   Total sample With sarcopenia Without sarcopenia 
 Obs. % Obs. % Obs. % 
Female  126 765 54.9 19 991 66.2 106 774 53.2 
Male  104 066 45.1 10 202 33.8 93 864 46.8 
Total  230 831 100 30 193 100 200 638 100 
  Mean Std. Dev. Mean Std. Dev. Mean Std. Dev. 
Age 65.7 9.8 74.5 10.2 64.4 9.0 
Grip strength female  26.3 7.1 15.2 3.4 28.3 5.5 
Grip strength male  42.8 10.4 23.6 4.9 44.8 8.5 
Body mass index  26.8 4.6 28.5 4.9 26.9 4.5 
Household income12 €30 085 €48 960 €21 304 €43 596 €31 398 €49 579 
               
SHARE is an unbalanced panel. Although the panel structure allows to follow the same 
individuals over many waves, not all questions were asked in all waves and to all respondents. 
Additionally, attrition reduces the size of the sample. Table II in the appendix lists the variables 
that are crucial to build the econometric models and the documented loss of observations due to 
the inclusion of these variables. Note that the prevalence of sarcopenia is higher in the southern 
parts of Europe, confirming previous findings of Andersen-Ranberg et al. (2009). 13 
            Figure I displays the percentage of individuals with sarcopenia of the total sample by age 
group and gender. As expected, people with sarcopenia are on average older. The charts 
demonstrate that sarcopenia is highly correlated with age and that the prevalence of sarcopenia 
                                                
11 The percentages are obtained from Table I and divided by the total sample.  
13%: 30 193/ 230 831, 15.8%: 19 991/126 765, 9.8%: 10 202/104 066.  
12 Household income is a SHARE imputed variable based on total monthly household income.  
13 Table I in the appendix presents the proportion of individuals with sarcopenia by country. The prevalence of 
sarcopenia is higher in the southern parts of Europe. In particular, Spain, Portugal and Israel have high proportions 
of individuals with sarcopenia. This confirms the findings of Andersen-Ranberg et al. (2009) that grip strength in 
northern and continental Europe is higher than in southern Europe.   
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increases progressively with age for men and women. The pattern in Figure I motivates for a more 
detailed analysis of the relationship between ageing and sarcopenia.14                                               
Figure I: Percentage of Sample with Sarcopenia by Age Group, for Men and Women 
One of the hypotheses of this work project is that sarcopenia has a negative impact on healthy 
ageing. Prior to any estimations, Figure II plots the variables self-assessed health and age for men 
and women, with and without sarcopenia.  









Three clearly visible effects are present. First, men and women with sarcopenia (the two “flat” 
lines) and men and women without sarcopenia (the two “steep” lines) do not have similar self-
assessed health. Second, there is a substantial but declining difference between the self-assessed 
health for individuals with and without sarcopenia at the age of 50, pointing in favor of the 
hypothesized effect. The difference is declining with age, reaching zero just before 100 years. 
                                                
14 Figure II in the supplementary appendix with respective explanation illustrates the intensity of sarcopenia, hence 
how far away from the cut-off value the handgrip strength is. The intensity can be viewed as a measure of the severity 
of sarcopenia. Most individuals with sarcopenia in the SHARE sample have a less “severe” version of sarcopenia.  
15 The ordered variable self-assessed health has the following values: (1) poor, (2) fair, (3) good, (4) very good and 
(5) excellent. Note that Figure II is created for exposition purposes. In the econometric specifications, self-assessed 
health is handled as an ordinal variable.  
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Third, the evolution of self-assessed health with age of individuals with sarcopenia is close to 
horizontal. A possible reason for this is that the self-assessed health status is, on average, so low 
that there is little room for deterioration. 
          Understanding how grip strength evolves over time also provides valuable insight on 
sarcopenia. A fixed effect model with grip strength as the dependent variable is estimated for men 
and women (see Table III in the appendix for estimation results).16 The explanatory variables 
include age, sarcopenia and an interaction term between sarcopenia and age (𝑠𝑎𝑟𝑐𝑜𝑎𝑔𝑒). The grip 
strength for men and women with and without sarcopenia is constructed as follows: 
 
𝐺𝑟𝑖𝑝	  𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ/0
= 𝛽3(𝑎𝑔𝑒) ∗ 𝑎𝑔𝑒/0 + 𝛽8(𝑠𝑎𝑟𝑐𝑜𝑝𝑒𝑛𝑖𝑎/0) ∗ 𝑠𝑎𝑟𝑐𝑜𝑝𝑒𝑛𝑖𝑎/0
+ 𝛽9(𝑠𝑎𝑟𝑐𝑜𝑎𝑔𝑒/0) ∗ 𝑠𝑎𝑟𝑐𝑜𝑎𝑔𝑒/0 + 𝛽:(𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡) 
(1) 
Using linear prediction, the grip strength is plotted in Figure III. Grip strength decreases with age. 
There is a substantial difference in the slope of the grip strength, with a steeper slope for 
individuals without sarcopenia for both men and women. The evolution of grip strength with age 
follows the same pattern as displayed in Figure II of self-assessed health and age.17  












In sum, the trends revealed in the presented figures suggest that sarcopenia is related to poor health 
outcomes. The following section explains the methodology of the models used to test if this is 
                                                
16 A methodical detail worth mentioning is that none of the estimations in this paper include any kind of sampling 
weights. The decision to not use weights is primarily based on Solon, Haider, and Wooldridges (2015) discussion of 
weights appliance. First, the objective of this paper is to capture the causal effect of sarcopenia, which is independent 
of weights, not to reflect the total population. Second, applying weights to the highly unbalanced panel is not desirable 
as that would lead to the sample being reduced significantly. Third, as some of the variables in the estimation are also 
used in the creation of the weights (gender, age etc.), this may disturb the weight structure and reduce the accuracy 
of the estimation coefficients. 
17 Due to biological differences, a 10 kg difference between men and women implies they are equally “well”.	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true. First, the SAI and AAI are presented to establish if sarcopenia has an effect on healthy 
ageing, followed by a production function of sarcopenia that may be useful to understand the 
determinants and potential interventions of the condition.  
3.2 Selfie Aging Index  
Using the work of Gonçalves et al. (2017) as reference, the SAI is replicated. The dependent 
variable, self-assessed health, reported as a five-level variable from poor to excellent, is recoded 
to three levels (poor or fair – good – very good or excellent). The SAI is based on an ordered 
probit model, predicting a selfie of each individual’s ageing status.18 The predicted latent variable 
is then normalized to a 0 to 1 scale, 1 being the best self-assessed health and 0 being the worst 
self-assessed health.19  
The original SAI is constructed using SHARE. The variables used in the creation of the 
SAI can be found in Table V in the appendix. The individual SAI score is obtained by inserting 
personal characteristics into the model.20 An additional feature is the data added on grip strength 
to analyze the effect of sarcopenia on the SAI. Another extension is the inclusion of all available 
waves in the model.21 The SAI is originally developed for Portugal. To make it suitable for this 
paper all SHARE countries are included, with time- and country dummies to control for time- and 
place specific effect. Robust standard errors were used in all models to control for 
heteroscedasticity.  
As previously mentioned, a limitation in using all waves is the large number of missing 
values for some of the variables. Consequently, the sample size is heavily reduced. Given the 
large number of missing variables, the SAI is predicted two times, one using the complete set of 
covariates and one excluding variables with many missing values.22 The correlation between the 
                                                
18 None of the models, except for the estimation of the grip strength (Table III in the appendix), uses fixed effect 
specifications. Using fixed effect on a highly unbalanced panel will reduce the sample heavily. Even if fixed effect 
models capture the effect of unobserved heterogeneity, the number of unknown parameters will increase with the 
number of observations. Additionally, the specification do not allow for estimation of coefficients that have no within-
subject variation (Hsiao 2007).  
19 The rescaling of the SAI allows for a more intuitive interpretation and is obtained by plugging in theoretical 
minimum and maximum values in the SAI, which is then normalized.  
20 See Figure III in and Figure IV in the supplementary appendix the distribution of the SAI and an illustration on 
the SAI in practice. For more details on the SAI, please refer to Gonçalves et al. (2017). 
21 All waves (1 to 6), except for Wave 3 (SHARELIFE), are included in the model. Wave 3 diverges from the other 
waves as it contains data on the respondents' life histories. The original SAI only uses the first four waves.  
22 Missing values >100 000.  
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two predicted variables is high, suggesting a similar effect for both models.23 To capture the full 
effect of the SAI, the model with the complete set of covariates is presented.  
3.3 Active Ageing Index  
The AAI is based on country-level average values of active ageing. Nonetheless, information on 
micro-level can be useful to understand each individual’s ageing status and outliers, such as 
people with sarcopenia. Therefore, following the method of Almeida and Barros (2015), the AAI 
is transformed from aggregate to individual level. Nine indicators from SHARE were selected to 
fit the four AAI domains. The number of missing values per variable was also considered in the 
selection to avoid losing too many observations. The variables and the composition of the domains 
can be found in Table V and Equation (4) in the appendix.  
Two versions of the AAI are constructed, with different composition of the first domain. 
One follows the Zaidi et al. (2017), where the first domain consists of a binary variable with value 
1 if the respondent is employed and 0 otherwise. In the other version, proposed by Almeida and 
Barros (2015), the first domain also includes an interaction term between the binary variables 
Social participation and Retired. Almeida and Barros argues that this version is more suitable at 
the individual level as respondents may be active after retirement.  
All non-dummy variables are normalized to a 0-1 interval.24 Linear regression is used to 
estimate the relation to socio-demographic characteristics, health care characteristics and social 
activity25. Additionally, a dummy variable for sarcopenia was included with the objective to find 
the impact of sarcopenia on the AAI: 
𝐴𝐴𝐼 = 𝑓(	  𝑠𝑎𝑟𝑐𝑜𝑝𝑒𝑛𝑖𝑎/, 𝑥/) (2) 
𝑥/  denotes the other characteristics to estimate on the AAI (see Table VI in the appendix). 
The transition from macro to micro-level poses challenges of finding appropriate variables 
for each indicator. The AAI's at the individual level are unique and depend on the variables 
selected. Adding up the AAI's do not produce an aggregate level AAI. Even if each domain 
                                                
23 Correlation between yComplete set of covariates and yIncomplete set of covariates  is 0.967.  
24 Using 𝑓(𝑥/)@= 
A BC DEFG	  (A BC )
EHI A BC DEFG	  (A BC )
.  
25 None of the variables used in the construction of the AAI are included in the estimation.  
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captures some of the dimensions of the AAI, some indicators are not reflected due to a lack of 
appropriate variables in the SHARE database.26  
3.4 Production Function of Sarcopenia 
The production function of sarcopenia is estimated using a binary probit model with sarcopenia 
as the variable of interest. The model has the following function:  
 𝑃 𝑦/ = 1|𝑥/ = 𝑓(𝑥´/𝛽) (3) 
where 𝑥´/ denotes the determinants of sarcopenia, presented in Table II and 𝑦/ equals 1 if the 
individual has sarcopenia and 0 otherwise.  
Table II: Variables for the Production Function of Sarcopenia 
Variable Descriptions 
Dependent variable   
Sarcopeniai 
= 1 if grip strength <20 kg (female) or <30 kg (male), 0 otherwise, 
 𝑖 ∈ 𝑚𝑎𝑙𝑒, 𝑓𝑒𝑚𝑎𝑙𝑒  
Independent variables  
Age Age of respondent at the time of the interview  
Moderate physical 
activity  
Respondent´s engagement in moderate physical activity categorized as follows: more than 
once a week, once a week, 1-3 times a month, (almost) never 
Vigorous physical 
activity  
Respondent´s engagement in moderate physical activity categorized as follows: more than 
once a week, once a week, 1-3 times a month, (almost) never  
BMI Body mass index categorized as follows: undernourished (<18.5), normal (18.5-25), overweight (25-30), obese (>30) 
Nursing home = 1 if the respondent has been in a nursing home the last 12 months, 0 otherwise 
Chronic diseases  Number of chronic diseases (self-reported) 
Self-assessed health  = 1 if the respondent has good, very good or excellent self-assessed health, 0 otherwise  
Number of difficulties 
in the ADLs Number of limitations with activities of daily living (in units)  
Number of difficulties 
in the IADLs  Number of limitations with instrumental activities of daily living (in units)  
Years of education  Number of years of education 
Income  Monthly household income (in euros)  
Married = 1 if the respondent is married or lives in a partnership, 0 otherwise 
 
            In sum, the SAI and AAI are constructed indices to measure healthy ageing. The SAI is 
an ordered probit based on self-assessed indicators and the AAI a weighted average of four 
domains capturing different aspects of healthy ageing. The explanatory variables included in the 
production function are based on existing literature on sarcopenia. The next section presents 
results of the SAI, the AAI and the production function of sarcopenia, respectively.  
 
 
                                                
26 For instance, SHARE do not contain useful information on physical safety, which is a part of the third domain of 
AAI, Independent, Healthy and Secure Living. 
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4.   Results 
4.1 Selfie Aging Index  
Table III presents the marginal effect of sarcopenia and age for the ordered probit estimation of 
the SAI.27 Consistent with the hypothesis, having sarcopenia is associated with a lower SAI score. 
Men and women with sarcopenia have a higher probability of reporting poor or fair self-assessed 
health and a lower probability of reporting good, very good or excellent self-assessed health 
compared to men and women without sarcopenia. For instance, being a man with sarcopenia 
increases the probability of reporting poor or fair self-assessed health by approximately 6 
percentage points on average, ceteris paribus.  
 
Table III: Marginal Effect of Sarcopenia on the Selfie Aging Index  
  Poor or fair Good Very good or excellent 
Sarcopeniamale   0.059***   (0,012) -0.007***   (0,001) -0.052***  (0,011) 
Sarcopeniafemale   0.061***   (0,010) -0.007***   (0,001) -0.053***  (0,009) 
Age  0.022***   (0,012) -0.003***   (0,007) -0.019***  (0,011) 
Age2 -0.0001*** (0,000)  0.00002***(0,000)  0.0001*** (0,000) 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
To have a reference of the magnitude of the impact, the marginal effect of sarcopenia is compared 
to the marginal effect of age. As previously illustrated (Figure I), age has a strong association with 
sarcopenia, hence age may be useful for comparison. Table IV presents the computed equivalent 
age effect.28 For each self-assessed health state, the marginal effect of sarcopenia on the SAI is 
equivalent to having approximately seven to ten years of age increase.29  
  
Table IV: Age Equivalent Effect of Sarcopenia on the Selfie Aging Index 
  Poor or fair Good Very good or excellent 
Male  6 years and 9 months 10 years 10 years 
Female  7 years 9 years 10 years 
 
                                                
27 The estimation results for the SAI can be found in Table VII in the appendix. 
28 For details of how the equivalent age effect of sarcopenia on the SAI is found, please refer to the appendix and 
Equation (5) with respective explanation.  
29 The effect of sarcopenia on the SAI may be perceived as small compared to the fitted lines of self-assessed health 
for men and women in Figure II. To test this, an ordered probit model on self-assessed health with sarcopenia and 
age as explanatory variables is estimated. While the marginal effect of age is similar in both regressions, the marginal 
effect of sarcopenia increases substantially. This may imply that the other indicators in the SAI capture some of the 
effect and that Figure II overestimates the effect of sarcopenia. See Table IV and V in the supplementary appendix 
for estimation results and marginal effects.  
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4.2 Active Ageing Index  
Table V presents the estimation results of the AAI following the approach of Almeida and 
Barros.30 Model 2 excludes non-significant variables. Sarcopenia has a negative impact on the 
AAI. The effect is greater for men than women. The marginal effect of sarcopenia is compared to 
the marginal effect of age. Note that the outcome value needs to be converted from the normalized 
values to the age to find the equivalent age effect.31 The impact of sarcopenia on the AAI is 
equivalent to having aged nine additional years for women and thirteen additional years for men, 
on average, ceteris paribus.32 
Table V: Factors Associated with the Active Ageing Index 
VARIABLES Model 1 Model 2 
Sarcopeniamale  -0.045*** (0.005)  -0.045*** (0.005) 
Sarcopeniafemale  -0.033*** (0.003)  -0.034*** (0.003) 
Gender: female  -0.025*** (0.002)  -0.025*** (0.002) 
Age   -0.185*** (0.016)  -0.165*** (0.006) 
Age2    0.036 (0.032)   
BMI   -0.116*** (0.017)  -0.119*** (0.017) 
Low education  -0.059*** (0.002)  -0.060*** (0.002) 
Married   0.002 (0.002)   
Health limitations   -0.022*** (0.002)  -0.022*** (0.002) 
Mental health  -0.008*** (0.002)  -0.008*** (0.002) 
Receive help  -0.008*** (0.002)  -0.008*** (0.002) 
Give help   0.027*** (0.002)   0.027*** (0.002) 
Constant   0.517*** (0.009)   0.516*** (0.008) 
     











Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
To understand what domains are more affected by sarcopenia, individual regressions for each 
domain are estimated.33 Table VI shows the coefficients of sarcopenia for the four domains used 
to construct the AAI. The mean, maximum and minimum value for the domains are included to 
better assess the magnitude.  
 
 
                                                
30 Table I and Figure V in the supplementary appendix present the estimation results and the distribution of the AAI 
following the method of Zaidi et al. (2017). Both versions of the AAI give similar estimation results. The version 
inspired by Almeida and Barros is presented in the main text, as it is found to be more appropriate for the sample. 
31 Table II in the supplementary appendix converts normalized values to age.  
32 For details of how the equivalent age effect of sarcopenia on the AAI is found, please refer to the appendix and 
Equation (6) with respective explanation.	  
33 Complete estimation results on the domains can be found in Table III in the supplementary appendix.  
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Table VI: Output of Coefficients on Regression of the Active Ageing Index Domains 
AAI domains  Mean Min Max Sarcopeniamale Sarcopeniafemale 
D1: Employment and active 
retirement 0.215 0 0.5 -0.052*** (0.003) -0.022*** (0.002) 
D2: Participation in society 0.284 0 1 -0.057*** (0.006) -0.042*** (0.005) 
D3: Independent, healthy and 
secure living 0.907 0 1.3 -0.079*** (0.002) -0.112*** (0.002) 
D4: Capacity and enabling 
environment for active ageing 0.733 0 1  0.0016      (0.004)      -0.0011     (0.003) 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
As in the previous section, the effect of sarcopenia is compared to the effect of age. Each domain 
is subject to separate normalization. Table VII presents the approximate comparable effect of 
ageing on the domains for both genders.34 The non-linear relation between age and the AAI 
produces results where, at old ages, the effect of sarcopenia is equivalent to getting younger.35 A 
possible rational for this is that the oldest individuals represent outliers or survivors of the 
population. Their health may stand out from the average population causing the odd relationship. 
When analyzing the effect of the AAI and the domains, it is important to remember that the indices 
are constructed using variables that are suitable to replicate the original AAI. The validity of the 
indices cannot be guaranteed and the results need to be interpreted with caution. For all significant 
results, there is a positive age effect equivalent to having sarcopenia. There is, however, no clear 
trend for gender or for the domains. Further research could study if the gender gap is random and 
caused by the specific sample used or if there exists gender differences within the domains. 
Table VII: Age Equivalent Effect of Sarcopenia on the Active Ageing Index Domains36 
Domain Effect (male) Effect (female) 
D1. Employment and active retirement  5 years 2.5 years 
D2. Participation in society  2.5 years  4 years 
D3. Independent, healthy and secure living  3 years 1 year 
D4. Capacity and enabling environment for active ageing             No statistical significant effect 
 
 To sum up, both healthy ageing indices find consistent results suggesting that sarcopenia has a 
significant negative impact on healthy ageing. The equivalent age effect of sarcopenia is similar 
in both indices, signalizing robust results. Having established this relationship, the focus is moved 
to the production function of sarcopenia for an analysis of the determinants of the condition.  
                                                
34 See Equation (5) in the appendix for computation of the equivalent age effect of the domains.  
35 The effect of sarcopenia is equivalent to getting younger at approximately 85 years in the second and third 
domain.  
36 The outcome value needs to be converted to the real age using Table II in the supplementary appendix. 	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4.3 Production Function of Sarcopenia 
The marginal effect of the production function is presented in Model (1) of Table VIII.37 In line 
with existing literature, the results suggests that doing less (compared to doing more) moderate 
and vigorous activity increases the likelihood of sarcopenia. However, physical activity may be 
related to reverse causality. It is difficult to determine if people who exercise have a lower 
probability of developing sarcopenia, or if people who do not have sarcopenia are more likely to 
exercise. Time spent on physical activity has a positive effect on health outcomes and can slow 
down the effects of ageing by increasing the number of healthy days in the future. Similarly, being 
physically inactive is likely to cause loss of muscle mass at the same time as low muscle mass 
may cause physical inactiveness. To the extent of my knowledge, no existing literature addresses 
this issue. 
            The risk of endogeneity is addressed by using the lag of the potential endogenous 
explanatory variables in the model.38 Model (2) presents the marginal effects of the production 
function in which the variables of physical activity are proxied by lagged variables. The marginal 
effects from the model with lagged variables are overall in line with the original variables, hence 
the potential source of endogeneity is not a serious problem.39 
            Never doing, or hardly ever doing vigorous physical activity (compared to doing vigorous 
physical activities more than once a week) has the same effect on the likelihood of developing 
sarcopenia as if the individual had 10 (men) and 21 (women) chronic conditions.40 This 
comparison emphasizes the importance of physical activity as a preventive tool and a possible 
intervention strategy. Moreover, the cost of implementing exercise plans are likely to be marginal 
compared to the health care costs of chronic conditions.   
                                                
37 Estimation results from the production function can be found in the supplementary appendix, Table VI. 
38 In detail, an ordered probit model is estimated with moderate and vigorous activity as the dependent variables and 
lagged explanatory variables. Variables from a previous period can be used as an instrument because it is less likely 
to be correlated with the future. The latent variables of physical activity are predicted and transformed into the same 
categories as the originals. The production function is estimated again, replacing the suspected endogenous variables 
with the predicted to compare. The sign and magnitude of the marginal effects for the two models have the same sign 
and magnitude, with some exceptions. For men, the lagged variable of vigorous physical activity, “Hardly ever, or 
never”, has a negative, but non-significant, sign (and differs from the original variable by <0.02), contradicting the 
existing literature. See estimation results in Table VII in the supplementary appendix.  
39 Since the predicted variables are proxies, the estimation results may lose precision. 
40 Equivalent effect is confirmed using a linear hypothesis test in Stata.   
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             The results suggest that age increases the likelihood of developing sarcopenia, supporting 
Figure I and the observations made in existing literature that the prevalence of sarcopenia 
increases with age.41 Sarcopenia is also associated with living in nursing homes. Having at least 
good self-assessed health is negatively related to sarcopenia. The number of difficulties in the 
ADLs and IADLs are positively related to sarcopenia. However, one also need to interpret these 
three latter factors with caution as they may be related to reverse causality.42  
The marginal effect of BMI suggests that if a respondent´s BMI is different from normal 
(undernutrition, overweight or obese), he or she is less likely to have sarcopenia (with the 
exception of undernourished women). This association suggests that, using SHARE, low or high 
BMI are not determinantants of sarcopenia.   
         Income has no significant effect on the onset of sarcopenia. Descriptive statistics (Table I) 
illustrate that people with sarcopenia have lower mean values of income. As previously 
mentioned, there is a substantial difference of sarcopenia between the south and north of Europe, 
with a higher prevalence in the south, where income is, on average, lower. Therefore, it could be 
that the difference in income is due to the higher proportion of people with sarcopenia in the south 
of Europa, and that this is accounted for by country dummies in the estimation.  
           Summing up, the results from the production function point towards physical activity being 
an important predictor of sarcopenia, and that doing less physical activity increases the liklihood 
of developing the condition. While there is no clear relation between BMI and sarcopenia or 
income and sarcopenia, the condition is found to be positively associated with limitations in daily 




                                                
41 The model is also estimated including the variables Retired (dummy variable) and Age,2 and with only Age2, see 
Model (1), (2) and (3) Table VI and Table VII in the supplementary appendix. Age2 is only significant when combined 
with Retired. This means Retired introduces a non-linearity on age. Being retired is age-related, hence Retired can be 
viewed as a proxy for age.  
42There is a risk that Self-assessed health, Number of difficulties in the ADLs- and IADLs suffer from revered 
causality. It is for instance difficult to establish if low self-assessed health causes sarcopenia, or if it is the other way 
around. Due to this suspicion, the production function was estimated without Self-assessed health, Number of 
difficulties in the ADLs- and IADLs in Table VII and VIII (Model (4) in the supplementary appendix).  
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Table VIII: Marginal Effects (ME) from the Production Function of Sarcopenia 
VARIABLES ME Male (1)  ME Male (2) ME Female (1) ME Female (2) 
Age   0.002***    0.002***   0.002***   0.002*** 
 (0.0001)   (0.0001)  (0.0001)  (0.0001) 
Moderate physical activity (ref: More than once a week)  
Once a week -0.0007    0.004*  
  (0.002)   (0.002)   
Once to three times a month   0.001     0.006*  
  (0.002)   (0.003)  
Hardly ever, or never   0.003**    0.011***  
  (0.002)   (0.002)  
Lagged moderate physical activity (ref: More than once a week)  
Once a week    0.006**    0.016*** 
   (0.002)   (0.004) 
Once to three times a month    0.011**     0.036*** 
	     (0.004) 	    (0.005) 
Hardly ever, or never    0.015**    0.057*** 
   (0.004)   (0.006) 
Vigorous physical activity (ref: More than once a week)   
Once a week   0.0002    0.009***  
  (0.002)   (0.002)  
Once to three times a month   0.002    0.006**  
  (0.002)   (0.021)  
Hardly ever, or never  0.010***    0.021***  
  (0.001)   (0.002)  
Lagged vigorous physical activity (ref: More than once a week)   
Once a week    0.038     0.012** 
   (0.004)    (0.006) 
Once to three times a month    0.003     0.016 
   (0.007)    (0.011) 
Hardly ever, or never   -0.008     0.009 
   (0.007)    (0.015) 
BMI (ref: normal weight)    
Undernourished  -0.011  -0.016***   0.035***  -0.029** 
  (0.004)  (0.004)  (0.008)  (0.014) 
Overweight  -0.004***  -0.001***  -0.017***  -0.021*** 
  (0.001)  (0.002)  (0.002)  (0.003) 
Obese  -0.008***  -0.006***  -0.015***  -0.017*** 
  (0.002)  (0.002)  (0.002)  (0.003) 
Nursing home   0.011***   0.016***   0.031   0.031* 
  (0.006)  (0.010)  (0.010)  (0.016) 
Chronic diseases   0.001***   0.001***   0.001**  -0.001 
  (0.0004)  (0.0001)  (0.001)  (0.001) 
Years of education   0.0001   0.0002  -0.002***  -0.002*** 
  (0.003)  (0.0002)  (0.0001)  (0.0003) 
Income/10 000  -0.0001 -0,0000007 -0.00003 (0.00005) 
 (0.0002) (0,0001) (0.0001) (0.003) 
Married   0.013***   0.016***  -0.020***  -0.022*** 
  (0.024)  (0.002)  (0.001)  (0.002) 
L.sarcopeniamale
43  0.106***   0.108***   
  (0.029)  (0.026)   
L.sarcopeniafemale    0.158***   0.173*** 
    (0.002)  (0.002) 
Self-assessed health   -0.012***  -0.009***  -0.023***  -0.068*** 
  (0.001)  (0.002)  (0.002)  (0.003) 
Number of difficulties in the ADLs   0.002***   0.002***   0.004***   0.004*** 
   (0.001)   (0.001)  (0.001)  (0.002) 
                                                
43 L.sarcopeniai is a lag operator controlling for if the respondent already has sarcopenia in the previous wave. 
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Number of difficulties in the IADLs   0.005***   0.007***   0.006***   0.005*** 
   (0.001)   (0.001)  (0.001)  (0.002) 
     
Observations 84 611 38 239 84 611 38 239 
Country dummies YES YES YES YES 
Year dummies YES YES YES YES 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
5.   Limitations  
SHARE is a rich, but unbalanced dataset. The unbalanced structure poses challenges in 
finding appropriate variables without losing too many observations. Moreover, the structure of 
the data has implications for the econometric specifications, for instance the decision to not use 
sample weights and fixed effect models.       
 Another challenge is related to how to measure healthy ageing. Because there is no explicit 
way of measuring healthy ageing, both the SAI and the AAI are used. As both the indices produce 
consistent results with regards to the effect of sarcopenia, it is taken as a promising sign that the 
healthy ageing concept is captured.44  
Additionally, literature on sarcopenia and its determinants is limited, as most of it is 
focused on biological and medical sciences rather than health and socioeconomic aspects. This 
posed challenges in determining which variables to include in the production function.  
     Due to the suspicion that physical activity, self-assessed health, living in a nursing home 
and the number of difficulties in the ADLs and IADLs are endogenous, one needs to interpret the 
estimates with caution. Further research should address the potential endogeneity bias and look 
for suitable instrumental variables to test for endogeneity. Additionally, further research could 
test and potentially confirm the established negative relationship between healthy ageing and 
sarcopenia, for example using difference-in-difference or matching estimation approaches.  
6.   Concluding Remarks  
This work project finds evidence suggesting that sarcopenia has a significant negative effect on 
healthy ageing, measured using the Selfie Aging Index and the Active Ageing Index. Sarcopenia 
has the same impact as having aged an additional of seven to ten years on the SAI and nine to 
                                                
44 The Selfie Aging Index is based on self-assessed measures while the Active Ageing Index is based on UNECE and 
EC´s method and converted from the aggregate to the individual level.  
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thirteen years on the AAI.45 The equivalent age effect is similar for both indices, enhancing the 
external validity of the estimation results. Considering the importance of healthy ageing and that 
self-assessed health is a proxy for healthy ageing, the low self-assessed health of people with 
sarcopenia may imply considerable loss of healthy ageing potential.    
           Results from the production function suggest that doing physical activity decreases the 
likelihood of developing sarcopenia. Sarcopenia is also found to be associated with limitations of 
daily living activities and living in nursing homes. The findings could indicate that people with 
sarcopenia have a high dependency on others, which may imply extra costs for the society, for 
example through additional caretaking. Interventions should target those at risk of developing 
sarcopenia, for example by creating targeted exercise plans and encourage people to engage in 
physical activities.46 This can for instance be implemented in nursing homes, especially for people 
under recovery, where the activity level may be lower than usual and people are extra prone to 
muscle loss.  
           With the demographic shift the world is facing today, the prevalence of sarcopenia is 
expected to rise significantly. The established negative relationship between healthy ageing and 
sarcopenia must be addressed. Focus should be on reaching a commonly agreed definition of the 
condition to establish effective treatment. Moreover, research should look for possible 
interventions to prevent the condition, minimize the negative consequences and increase the 
number of healthy life years for people with sarcopenia. 
 
7.   References 
 
Almeida, S., and P. P. Barros. 2015. “How Relevant Is Active Ageing? Evidence from Portugal.” In Building 
Evidence for Active Ageing Policies, 313–41. https://doi.org/10.1007/978-981-10-6017-5_15. 
Andersen-Ranberg, K, I. Petersen, H. Frederiksen, J. P. Mackenbach, and K. Christensen. 2009. “Cross-National 
Differences in Grip Strength among 50+ Year-Old Europeans: Results from the SHARE Study.” European 
Journal of Ageing 6 (3): 227–36. https://doi.org/10.1007/s10433-009-0128-6. 
Börsch-Supan, A., C. Brandt, T. Hunkler, J. Kneip, F. Korbmacher, B. Malter, S. Schaan, S. Stuck, and Zuber. 2013. 
“Data Resource Profile: The Survey of Health, Ageing and Retirement in Europe (SHARE).” International 
Journal of Epidemiology. https://doi.org/10.1093/ije/dyt088. 
                                                
45 Sarcopenia is equivalent to having aged an additional of thirteen years for men and nine years for women, using 
the AAI estimations. 	  
46 Resistance training interventions for older people have been shown to be highly effective, with particularly large 
positive effects on muscle strength (Liu and Latham 2009). 
 20 
Cruz-Jentoft, A. J., J. P. Baeyens, J. M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F. Martin, et al. 2010. “Sarcopenia: 
European Consensus on Definition and Diagnosis.” Age and Ageing 39 (4): 412–23. 
https://doi.org/10.1093/ageing/afq034. 
Downward, Paul. 2007. “Exploring the Economic Choice to Participate in Sport: Results from the 2002 General 
Household Survey.” International Review of Applied Economics 21 (5): 633–53. 
https://doi.org/10.1080/02692170701474710. 
Engel, G. L. 1977. “The Need for a New Medical Model: A Challenge for Biomedicine.” Psychodynamic Psychiatry 
40 (3): 377–96. https://doi.org/10.1521/pdps.2012.40.3.377. 
Gonçalves, J., M. I. Gomes, M. Fonseca, T. Teodoro, P. P. Barros, and M. Botelho. 2017. “Selfie Aging Index: An 
Index for the Self-Assessment of Healthy and Active Aging.” Frontiers in Medicine 4. 
https://doi.org/10.3389/fmed.2017.00236. 
Grossman, M. 1972. “On the Concept of Health Capital and the Demand for Health.” Journal of Political Economy 
80 (2): 223–55. http://www.jstor.org/stable/1830580. 
Gruber, S., C. Hunkler, and S. Stuck. 2014. “Generating EasySHARE: Guidelines, Structure, Content and 
Programming. SHARE Working Paper Series.” 17-2014. Munich: MEA, Max Planck Institute for Social 
Law and Social Policy. 17–2014. https://doi.org/10.6103/SHARE.easy.610. 
Hsiao, C. 2007. “Panel Data Analysis—advantages and Challenges.” TEST 16 (1): 1–22. 
https://doi.org/10.1007/s11749-007-0046-x. 
Liu, C., and N. Latham. 2009. “Progressive Resistance Strength Training for Improving Physical Function in Older 
Adults.” The Cochrane Database of Systematic Reviews, no. 3 (July): CD002759. 
https://doi.org/10.1002/14651858.CD002759.pub2. 
Martone, A. M., F. Lattanzio, A. M. Abbatecola, D. L. Carpia, M. Tosato, E. Marzetti, R. Calvani, G. Onder, and F. 
Landi. 2015. “Treating Sarcopenia in Older and Oldest Old.” Current Pharmaceutical Design 21 (13): 
1715–22. https://moh-it.pure.elsevier.com/en/publications/treating-sarcopenia-in-older-and-oldest-old. 
Mossey, J. M., and E. Shapiro. 1982. “Self-Rated Health: A Predictor of Mortality among the Elderly.” American 
Journal of Public Health 72 (8): 800–808. https://doi.org/10.2105/AJPH.72.8.800. 
Muscaritoli, M., S. D. Anker, J. Argilés, Z. Aversa, J. M. Bauer, G. Biolo, Y. Boirie, et al. 2010. “Consensus 
Definition of Sarcopenia, Cachexia and Pre-Cachexia: Joint Document Elaborated by Special Interest 
Groups (SIG) ‘Cachexia-Anorexia in Chronic Wasting Diseases’ and ‘Nutrition in Geriatrics.’” Clinical 
Nutrition 29 (2): 154–59. https://doi.org/10.1016/j.clnu.2009.12.004. 
Paúl, C., O. Ribeiro, and L. Teixeira. 2012. “Active Ageing: An Empirical Approach to the WHO Model.” Current 
Gerontology and Geriatrics Research. https://doi.org/10.1155/2012/382972. 
Pfarr, C., A. Schmid, and U. Schneider. 2012. “Reporting Heterogeneity in Self-Assessed Health among Elderly 
Europeans.” Health Economics Review 2 (October): 21. https://doi.org/10.1186/2191-1991-2-21. 
Ryu, M., J. Jo, Y. Lee, Y. Chung, K. Kim, and W. Baek. 2013. “Association of Physical Activity with Sarcopenia 
and Sarcopenic Obesity in Community-Dwelling Older Adults: The Fourth Korea National Health and 
Nutrition Examination Survey.” Age and Ageing 42 (6): 734–40. https://doi.org/10.1093/ageing/aft063. 
Solon, Gary, Steven Haider, and Jeffrey M. Wooldridge. 2015. “What Are We Weighting For?” Journal of Human 
Resources 50 (2): 301–16. http://jhr.uwpress.org/cgi/reprint/50/2/301. 
The Swedish National Institute of Public Health. 2007. Healthy Ageing: A Challenge for Europe. Sweden, 
Stockholm: National Institute of Public Health. 
http://ec.europa.eu/health/ph_projects/2003/action1/docs/2003_1_26_frep_en.pdf. 
UNECE/ European Commission. 2015. “Active Ageing Index 2014: Analytical Report.” Report Prepared by Zaidi. 
A. of Centre for Research on Ageing, University of Southampton and David Stanton, under Contract with 
United Nations Economic Commission for Europe (Geneva), Co-Funded by European Commission’s 
Directorate General for Employment, Social Affairs and Inclusion (Brussels). 
https://ec.europa.eu/eip/ageing/library/2014-active-ageing-index-aai-analytical-report_en. 
World Health Organization, ed. 2015. World Report on Ageing and Health. Geneva, Switzerland: World Health 
Organization. http://www.who.int/ageing/events/world-report-2015-launch/en/. 
Yu, S., K. Khow, A. Jadczak, and R. Visvanathan. 2016. “Clinical Screening Tools for Sarcopenia and Its 
Management.” Current Gerontology and Geriatrics Research. https://doi.org/10.1155/2016/5978523. 
Zaidi, A., M. Barslund, and M. V. Werder. 2017. “Inequality in Active Ageing: Evidence from a New Individual-






Table I: Proportion of Individuals with Sarcopenia Per Country47 
Country Proportion Country Proportion Country Proportion 
Germany 7,5% Luxembourg 10,7% Greece 14,2% 
Netherlands 8,1% Belgium 10,8% France 14,2% 
Denmark 8,2% Croatia 12,2% Italy 15,1% 
Sweden 9,0% Slovenia 12,3% Hungary 16,6% 
Czech Republic 9,4% Poland 13,0% Portugal 22,8% 
Switzerland 9,6% Estonia 13,1% Israel 23,0% 
Austria 10,0% Ireland 13,6% Spain 26,9% 
 
 
Table II: Critical Variables Used in the Construction of the Indices 
Variable included  Sample size Index 
Sleep 191 506 SAI 
Lack of interest  170 435 SAI 
Social participation  169 950 AAI 
Cognitive difficulties  122 521 AAI 
Complaints: general  111 056 SAI 
Complaints: emotions  84 266 SAI 
Size of social network  51 734 SAI 
 
 
Table III: Estimation Results from Regression of Grip Strength Used for Figure III 
VARIABLES Grip strength (male) Grip strength (female)   
Sarcopeniamale  -39.720*** (0.679)   
Sarcoagemale48       0.364*** (0.009)   
Sarcopeniafemale     -21.00*** (0.288) 
Sarcoagefemale       0.170*** (0.004) 
Age    -0.458*** (0.003)   -0.232*** (0.002) 
     
Observations 94,902 115,615 






Number of merge_id 
Controls  
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
Table IV: Indicator Variables of the Selfie Aging Index 
Biological 
subdomains Variable Variable description 
Complaints 
about one´s 
health status  
Complaints: general Number of complaints, (falling, fear of falling, fatigue, other symptoms) 
Complaints: 
digestive system 
= 1 if the respondent is bothered by stomach or intestine problems, including 
constipation, air, diarrhea, 0 otherwise  
Complaints: eyesight = 1 if the respondent has fair or poor eyesight, 0 otherwise  
Complaint: hearing = 1 if the respondent has fair or poor hearing, 0 otherwise  
Complaints: 




= 1 if the respondent is bothered by pain in back, knees, hips or any other 
joints, 0 otherwise 
Complaints: nervous 
system = 1 if the respondent is bothered by dizziness, faints or blackouts, 0 otherwise  
                                                
47 See Figure I in the supplementary appendix for the proportion of people with sarcopenia per wave.  




= 1 if the respondent is bothered by breathlessness or persistent cough, 0 
otherwise  
Complaints: urinary 
system = 1 if the respondent is incontinence, 0 otherwise 
Nutrition status  BMI Body mass index categorized into the following intervals: undernourished (<18.5), normal (18.5-25), overweight (25-30) and obese (>30) 
Mobility  
Difficulties moving 
around = 1 if the respondent has difficulties walking across a room, 0 otherwise  
Number of 
difficulties in the 
ADLs49 
Number of difficulties the respondent has out of the following: difficulties 
bathing or showering, dressing, using the toilet, getting in and out of bed, 
eating,   
Number of 
difficulties in the 
IADLs 
Number of difficulties the respondent has out of the following: difficulties 
making telephone calls, shopping for groceries, preparing a hot meal, doing 
work around the house or garden, taking medication, managing money  
Psychological 





emotional status = 1 if the respondent has ever had affective or emotional disorders, 0 otherwise  
Depressed  = 1 if the respondent was sad or depressed last month, 0 otherwise   
Lack of interest  = 1 if the respondent is less interested than usual in things the last month, 0 otherwise  
Nervousness  Level of nervousness categorized as follows: never, hardly ever, some of the time and most of the time 
Trouble sleeping  = 1 if the respondent has trouble with sleep, 0 otherwise 
Lack of energy  = 1 if the respondent has little energy to do the things he or she wanted to do last month (fatigue), 0 otherwise  
Cognitive 
status  Time awareness  
= 1 if the respondent is time aware (knowledge of year, month, day of the 
month, day of the week), 0 otherwise 
Social domain    
Social network  
Marital status  Marital status categorized as follows: widowed, married, single, divorced/separated 
Lives with someone 
else = 1 if the respondent lives with someone (household size>1), 0 otherwise 
Has someone to 
confide with  = 1 if the respondent´s social network>1, 0 otherwise   
Social status  
Years of education  Number of years of education  
Job type  
Type of current or last job categorized as follows: manager or army official, 
professional, technician, clerk, service and sales, agriculture and fishing, 





Respondent´s engagement in vigorous physical activity categorized as 




Respondent´s engagement in moderate physical activity categorized as 
follows: more than once a week, once a week, 1-3 times a month, (almost) 
never  
Smoking status Smoking status categorized as follows: non-smoker, former smoker, current smoker  
Other    
 
Sarcopeniai  
= 1 if grip strength<20 kg (female) or <30 kg (male), 0 otherwise, 𝑖 ∈




       Construction of the Active Ageing Index:    







                                                
49 ADLs: Activities of daily living. IADLs: Instrumental activities of daily living  
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Table V: Variables and Weights for Construction of the Active Ageing Index 
 
 
Table VI. Variables for Regression of the Active Ageing Index 
  Variable name Description 
SD:Socio-
demographic 
Female = 1 if the respondent is female, 0 otherwise 
Age, Age2 Normalized age and age squared 
BMI Normalized body mass index 
Low education = 1 if the respondent has low education (primary or lower secondary education), 0 otherwise52 
                                                
50 Income was subject to normalization using 𝑓(𝑥/)@= 
A BC DEFG	  (A BC )
EHI A BC DEFG	  (A BC )
.  
51 Physically inactive refers to never (or almost never) being in vigorous or moderate activity.  













Currently working 50% 
Employed 








35% Currently working 100% 
Employed 











= 1 if the respondent did activities last year 









Monthly household income divided into 
intervals (in euros): 1 
1.Until 245, 246-489, 490-734, 735-1223, 
1224-2445, above 2445 




= 1 if the respondent has no 
limitations of activities of daily 
living (ADLs), 0 otherwise  
50% 
no_daily_instdiff 
= 1 if the respondent has no 
limitations with instrumental 
activities of daily living 
(IADLs), 0 otherwise 
Independent 25% 
Independent 
= 1 if the respondent lives alone or with only 




=1 if the respondent is not physically 







Cognitive difficulties 45% 
Cogn_diff 
The completion score of cognitive 
difficulties test (remembering test, 
orientation to date, mathematical 
performance) divided into the following 
intervals: 
until 25%, 26-50%, 51-75%, 76-100% 
Current health status 55% 
Self_health 
=1 if the respondent reports at least good 
self-assessed health, 0 otherwise  
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Married  = 1 if the respondent is married or in a registered partnership, 0 otherwise 
H: Health Care 
Characteristics 
Health limitation = 1 if the respondent has limitation in activities because of health, 0 otherwise 




Receive help53	   = 1 if the respondent has received help from others (outside household), 0 otherwise 
Give help  = 1 if the respondent has given help the last twelve months, 0 otherwise 
Sarc: Sarcopenia Sarcopeniai 
= 1 if grip strength <20 kg (female) or <30 kg (male), 0 otherwise, 
 𝑖 ∈ 𝑚𝑎𝑙𝑒, 𝑓𝑒𝑚𝑎𝑙𝑒  
 
 
Table VII: Selfie Aging Index Estimation Results from the Ordered Probit Model 
VARIABLES Model 1 Model 254 
Sarcopeniamale -0.236*** (0.048)  -0.231*** (0.047) 
Sarcopeniafemale -0.245*** (0.039)  -0.253*** (0.038) 
Gender: female  0.140*** (0.018)   0.132*** (0.017) 
Age -0.087*** (0.011)  -0.085*** (0.011) 
Age2  0.001*** (0.000)   0.001*** (0.000) 
Complaints: general -0.251*** (0.016)  -0.254*** (0.016) 
Complaints: digestive system  -0.235*** (0.025)  -0.230*** (0.024) 
Complaints: eyesight -0.211*** (0.017)  -0.214*** (0.016) 
Complaints: hearing  -0.308*** (0.022)  -0.311*** (0.021) 
Complaints: circulatory system -0.428*** (0.022)  -0.430*** (0.021) 
Complaints: musculoskeletal system -0.327*** (0.015)  -0.337*** (0.015) 
Complaints: nervous system  -0.250*** (0.033)  -0.266*** (0.032) 
Complaints: respiratory system -0.364*** (0.025)  -0.363*** (0.024) 
Complaints: urinary system -0.057 (0.045)   
BMI (ref: normal weight)     
Undernourished -0.176** (0.074)  -0.165** (0.071) 
Overweight -0.100*** (0.017)  -0.115*** (0.016) 
Obese -0.262*** (0.021)  -0.275*** (0.021) 
Difficulties moving around   0.217 (0.133)   
Number of difficulties in the ADLs -0.156*** (0.032)  -0.159*** (0.032) 
Number of difficulties in the IADLs -0.122*** (0.021)  -0.106*** (0.019) 
Complaints: emotional system -0.154*** (0.029)  -0.160*** (0.028) 
Depressed -0.153*** (0.017)  -0.148*** (0.017) 
Lack of interest  -0.071** (0.033)  -0.085*** (0.032) 
Nervousness (ref: never)     
Seldom  -0.004 (0.019)   -0.008 (0.019) 
Sometimes  -0.067*** (0.019)   -0.073*** (0.019) 
Often  -0.158*** (0.039)   -0.173*** (0.037) 
Trouble sleeping -0.185*** (0.017)   -0.184*** (0.017) 
Lack of energy  0.068*** (0.004)    0.068*** (0.004) 
Time awareness  0.003 (0.025)   
Marital status (ref: widowed)     
Married -0.066** (0.032)   -0.045* (0.026) 
Single -0.102** (0.040)   -0.089** (0.038) 
Divorced/separated   0.021 (0.034)    0.036 (0.033) 
Lives with someone else55   0.021 (0.028)   
                                                
53 Due to the nature of the data (many variables with many missing values), the indicators Give help and Receive help 
were chosen as proxies for social activity.  
54 Model 2 excludes variables that do not contribute to the overall fit of the model. In some aspects the SAI of Gonçalves 
et al. (2017) differentiates from this SAI. In particular, Number of difficulties in the IADLs, Complaints: emotional status, 
Time awareness, BMI and Smoking status were not significant in the original SAI, but significant in this version. On the 
other hand, Difficulties moving around, Has someone to confide with and Years of education were not significant in this 
model, but significant in the original version. All variables except for Lack of energy has the expected association with self-
assessed health.	  	  
55 As already addressed in Gonçalves et al. (2017) there is a risk of multicollinearity affecting the efficiency of the model, 
in particular between Living with someone and Marital status. Multicollinearity could cause unexpected estimates. The risk 
of multicollinearity was assessed by looking at the correlation matrix of covariates. Marital status and Living with someone 
were the only variables with high correlation (<0.6). In Model 2, Living with someone was excluded due to a non-significant 
coefficient, which automatically reduces the issue of multicollinearity. 
 25 
Has someone to confide with  -0.032 (0.042)   
Years of education   0.007 (0.008)   
Years of education2  0.001** (0.000)   
Type of job (ref: manager, army official)     
Professional -0.069* (0.038)   -0.051 (0.036) 
Technician -0.145*** (0.035)   -0.183*** (0.034) 
Clerk -0.158*** (0.035)   -0.216*** (0.033) 
Services and sales -0.229*** (0.034)   -0.317*** (0.032) 
Agriculture and fishing -0.380*** (0.045)   -0.513*** (0.043) 
Crafts -0.303*** (0.036)   -0.404*** (0.034) 
Blue collar -0.378*** (0.042)   -0.488*** (0.040) 
Elementary -0.359*** (0.037)   -0.487*** (0.034) 
Armed forces -0.143 (0.097)   -0.213** (0.095) 
Vigorous physical activities (ref: more than once a week)   
Once a week -0.140*** (0.023)    -0.142*** (0.022) 
1-3 times a week -0.166*** (0.027)   -0.165*** (0.026) 
(Almost) never -0.369*** (0.019)   -0.373*** (0.019) 
Moderate physical activities (ref: more than once a week)   
Once a week  -0.020 (0.022)    -0.011 (0.022) 
1-3 times a week  -0.133*** (0.034)    -0.132*** (0.033) 
(Almost) never  -0.203*** (0.034)    -0.219*** (0.033) 
Smoking status (ref: non-smoker)     
Former smoker   0,071***     -0.073 (0.015) 
Current smoker -0.051***      -0.054*** (0.049) 
     
Constant cut1 -4.798*** (0.364)   -4.943*** (0.350) 
Constant cut2 -3.431*** (0.363)   -3.581*** (0.349) 
     
Observations 28 375  30 105  
Pseudo R2 0.272  0.270  
Country dummies YES  YES  
Year dummies YES  YES  
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
Equivalent Age Effect of Sarcopenia for the SAI and the AAI Domains56  
𝑆𝐴𝐼	   = 	  𝑀𝐸3𝑎𝑔𝑒	   + 	  𝑀𝐸8	  𝑎𝑔𝑒8 	  + 	  𝑀𝐸9	  𝑠𝑎𝑟𝑐𝑜𝑝𝑒𝑛𝑖𝑎	   + 	  𝑘 (5) 
where 𝑘 denotes all the other factors of the index and 𝑀𝐸 is the marginal effect. When 
𝑑𝑆𝐴𝐼 = 0, and sarcopenia moves from 0 to 1,  
𝑑𝑆𝐴𝐼
𝑑𝑎𝑔𝑒
= 𝑀𝐸3𝑑𝑎𝑔𝑒	   + 	  𝑀𝐸8 ∗ 2 ∗ 𝑑𝑎𝑔𝑒	   + 	  𝑀𝐸9 = 0 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝑑𝑎𝑔𝑒	   = 	  −	  	   _`a
_`b	  c	  8	  ∗	  _`d	  ∗	  efg
	  for each observation.   






                                  when  𝐴𝐴𝐼 = 𝛽3𝑎𝑔𝑒 + 𝛽9𝑠𝑎𝑟𝑐𝑜𝑝𝑒𝑛𝑖𝑎/ + 𝑘  
𝑘 denotes all the other factors of the AAI.  
                                                
56 Equation (5) uses the SAI for illustration. The impact on the AAI is obtained in the same manner as the SAI. The impact 
is found by taking the average of the effect for all ages weighted by the number of people at each age. As the AAI uses a 






MEASURING AGEING BY A HANDSHAKE 
THE IMPACT OF SARCOPENIA ON HEALTHY AGEING 
 






Figures I: Proportions of Individuals with Sarcopenia per Wave and Country 
 
The prevalence of sarcopenia is higher in the southern parts of Europe. In particular, Spain, 
Portugal and Israel have high proportions of individuals with sarcopenia, while Germany, 
Netherlands, Denmark and Sweden have low proportions of individuals with sarcopenia. This 
confirms the findings of Andersen-Ranberg et al. (2009) that grip strength in northern and 








Figures II: Intensity of Sarcopenia for Men and Women, Respectively 
 
Figure II illustrates the grip strength of individuals with sarcopenia as a percentage of the cut-
off value (20 kg for women and 30 kg for men). Observations close to one means the 
individuals have very low levels of grip strength, while observations with values close to zero 
means the individuals have grip strength values close to the cut-off value, in other words they 
have a less “severe” version of sarcopenia. Men and women follow an equal pattern of an 
exponentially declining number of individuals when approaching “severe” sarcopenia. Having 
noted that sarcopenia is a condition defined by an exceptionally low handgrip strength, most 





















































Figure IV presents a hypothetical individual´s SAI score, presented along with the distribution 
of the SAI score of its peers (people aged plus/minus two years in the sample) with respective 
quintiles. The SAI score is obtained by inserting the individual´s characteristics into the model.  
 
The hypothetical individual is a female widow, aged 79 years from Estonia. She is a former 
smoker with sarcopenia has general complaints, complaints about the circularly system, the 
muscular system, the nervous system, the emotional system, has difficulties moving, is 
depressed and nervous, has trouble sleeping, has no loss of interest and is lacking energy, 
worked in service or sales, does moderate and vigorous activities more than once a week, is 




Figures V: Distribution of the AAI (ref: Zaidi et al.) and the AAI (ref: Almeida and Barros)  
 
Table I: Factors Associated with the Active Ageing Index, Second Approach (ref: Zaidi) 
VARIABLES Model 1 Model 2 
Sarcopeniamale  -0.046*** (0.004)  -0.046*** (0.004) 
Sarcopeniafemale  -0.027*** (0.003)  -0.027*** (0.003) 
Gender: female  -0.031*** (0.002)  -0.031*** (0.002) 
Age  -0.969*** (0.016)  -0.969*** (0.016) 
Age2   0.792*** (0.023)   0.792*** (0.022) 
BMI   -0.131*** (0.018)  -0.118*** (0.017) 
Low education  -0.065*** (0.002)  -0.065*** (0.002) 
Married   0.0003 (0.002)   
Health limitations   -0.036*** (0.002)  -0.036*** (0.002) 
Mental health  -0.010*** (0.002)  -0.010*** (0.002) 
Receive help  -0.009*** (0.002)  -0.009*** (0.002) 
Give help   0.023*** (0.002)   0.023*** (0.002) 
Constant   0.674*** (0.009)   0.674*** (0.009) 
     











Robust standard errors in parentheses 


















Table II: Conversion of Age to Normalized Values57 
Age Normalized Age Normalized Age Normalized 
50 0 68 0.346 86 0.692 
51 0.019 69 0.365 87 0.712 
52 0.038 70 0.385 88 0.731 
53 0.058 71 0.404 89 0.750 
54 0.077 72 0.423 90 0.769 
55 0.096 73 0.442 91 0.788 
56 0.115 74 0.462 92 0.808 
57 0.135 75 0.481 93 0.827 
58 0.154 76 0.500 94 0.846 
59 0.173 77 0.519 95 0.865 
60 0.192 78 0.538 96 0.885 
61 0.212 79 0.558 97 0.904 
62 0.231 80 0.577 98 0.923 
63 0.250 81 0.596 99 0.942 
64 0.269 82 0.615 100 0.962 
65 0.288 83 0.635 101 0.981 
66 0.308 84 0.654 102 1 
67 0.327 85 0.673 	    
 
 





                                                
57 The equivalent age effect is obtained by converting the normalized value to the real age using 
 𝑓(𝑥/)@= 
A BC DEFG	  (A BC )
EHI A BC DEFG	  (A BC )
, and subtracting the minimum age of the distribution (50).  
VARIABLES D1 D2 D3 D4 
Sarcopeniamale  -0.050*** (0.004)  -0.068*** (0.005) -0.083*** (0.003)   0.004 (0.003) 
Sarcopeniafemale  -0.027*** (0.003)  -0.040*** (0.004) -0.107*** (0.002)  -0.001 (0.002) 
Gender: female   -0.035*** (0.001)  -0.019*** (0.003)  0.007*** (0.001)  -0.002 (0.002) 
Age   -0.974*** (0.011)   0.207*** (0.030)  0.651*** (0.010)   0.256*** (0.013) 
Age2    0.771*** (0.001)  -0.362*** (0.030) -0.899*** (0.014)  -0.340*** (0.018) 
BMI  -0.168*** (0.011)  -0.281*** (0.021) -0.363*** (0.011)   0.364*** (0.013) 
Low education   -0.062*** (0.001)  -0.092*** (0.003) -0.020*** (0.001)  -0.004*** (0.002) 
Married    0.001 (0.001)   0.018*** (0.003) -0.029*** (0.001)   0.004** (0.002) 
Health limitations  -0.054*** (0.001)  -0.057*** (0.003) -0.093*** (0.001)   0.141*** (0.001) 
Mental health   -0.016*** (0.001)  -0.018*** (0.003) -0.035*** (0.001)   0.036*** (0.001) 
Receive help  -0.004*** (0.002)   0.005 (0.003) -0.059*** (0.001)   0.007*** (0.002) 
Give help    0.021*** (0.001)   0.068*** (0.003)  0.023*** (0.001)  -0.007*** (0.002) 
Constant   0.504*** (0.008)   0.401*** (0.014)  0.997*** (0.003)   0.552*** (0.005) 
         



















Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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Table IV: Estimation Results of the Ordered Probit of Self-Assessed Health (no controls) 
VARIABLES Model 1	  
Sarcopeniamale  -0.553*** (0.013) 
Sarcopeniafemale  -0.676*** (0.010) 
Age  -0.063*** (0.003) 
(Age2)/100   0.030*** (0.002) 
   
Constant cut1  -3.575*** (0.109) 
Constant cut2  -2.461*** (0.109) 
   




Pseudo R2  
Country dummies 
Year dummies 
Robust standard errors in parentheses 
                   *** p<0.01, ** p<0.05, * p<0.1  
  
Table V: Marginal Effects of Sarcopenia and Age on Self-Assessed Health58 
 Poor or fair Good Very good or excellent 
Sarcopeniamale 0.180*** (0,004) -0.017*** (0,000) -0.163*** (0,004) 
Sarcopeiafemale 0.220*** (0,003) -0.021*** (0,000) -0.129*** (0,003) 
Age 0.021*** (0,001) -0.002*** (0,000) -0.019*** (0,001) 
(Age2)/100 -0.009*** (0,001) 0.001*** (0,000) 0.009*** (0,001) 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
Table VI: Estimation Results from the Production Function of Sarcopenia  
VARIABLES Male (1) Male (2) Female (1) Female (2) 
Age 0.038*** 0.039***    0.024***    0.016*** 
   (0.001)   (0.002)   (0.001)   (0.002) 
Moderate physical activity (ref: More than once a week) 
Once a week   -0.013     0.044*  
   (0.032)    (0.024)  
Once to three times a month    0.018     0.062*  
   (0.043)    (0.034)  
Hardly ever, or never    0.063**     0.116***  
   (0.031)    (0.026)  
Lagged moderate physical activity (ref: More than once a week) 
Once a week     0.139*     0.217*** 
    (0.081)    (0.052) 
Once to three times a month     0.238***     0.421*** 
    (0.091)    (0.061) 
Hardly ever, or never     0.295***     0.602*** 
    (0.100)    (0.069) 
Vigorous physical activity (ref: More than once a week) 
Once a week    0.005     0.112***  
   (0.038)    (0.029)  
Once to three times a month    0.040     0.077**  
   (0.043)    (0.034)  
Hardly ever, or never    0.183***     0.238***  
   (0.028)    (0.022)  
Lagged vigorous physical activity (ref: More than once a week) 
Once a week     0.068     0.120** 
                                                
58 The marginal effects are derived from Table IV.  
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    (0.069)    (0.056) 
Once to three times a month     0.052     0.155 
    (0.124)    (0.100) 
Hardly ever, or never    -0.168     0.088 
    (0.173)    (0.142) 
BMI (ref: normal weight)    
Undernourished   -0.209**   -0.358***    0.296***    0.229** 
   (0.090)   (0.127)   (0.062)   (0.099) 
Overweight   -0.073***   -0.023   -0.185***    -0.213*** 
   (0.022)   (0.034)   (0.019)   (0.027) 
Obese   -0.148***   -0.107**   -0.161***   -0.165*** 
   (0.029)   (0.045)   (0.022)   (0.032) 
Nursing home    0.201    0.292    0.340***    0.311* 
   (0.127)   (0.188)   (0.112)   (0.159) 
Chronic diseases    0.020**    0.019    0.016**   -0.014 
   (0.009)   (0.014)   (0.007)   (0.011) 
Years of education    0.002    0.003   -0.017***   -0.017*** 
   (0.003)   (0.004)   (0.002)   (0.003) 
Income/10 000   -0.003   -0.0001   -0.0003    0.0005 
   (0.004)   (0.002)   (0.002)   (0.002) 
Married    0.241***   0.308***   -0.222***   -0.227*** 
   (0.024)   (0.038)   (0.017)   (0.002) 
L.sarcopeniamale    1.943***    2.017***   
   (0.028)   (0.043)   
L.sarcopeniafemale     1.754***    1.762*** 
     (0.021)   (0.030) 
Self-assessed health   -0.211***   -0.169***   -0.251***   -0.171*** 
   (0.023)   (0.037)   (0.019)   (0.029) 
Number of difficulties in the 
ADLs 
   0.037***    0.043    0.063***    0.039* 
   (0.010)   (0.027)   (0.008)   (0.023) 
Number of difficulties in the 
IADLs 
   0.099***    0.127***    0.043***    0.048** 
   (0.015)   (0.026)   (0.013)   (0.021) 
     
Constant   -5.080***   -5.428***    -3.167***   -2.770*** 
   (0.124)   (0.201)   (0.086)   (0.129) 
     
Observations 84 611 38 239 84 611 38 239 
Pseudo R2 0.373 0.391 0.366 0.372 
Country dummies YES YES YES YES 
Year dummies YES YES YES YES 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
Table VII: Estimation Results from the Production Function of Sarcopenia for Men 
VARIABLES Model (1) Model (2) Model (3) Model (4) 
Age   -0.040**    0.035**    0.032***    0.034*** 
   (0.016)   (0.015)   (0.002)   (0.001) 
Age2 0.000493***    2.64e-05   
   (0.0001)   (0.0001)   
Moderate physical activity (ref: More than once a week)  
Once a week   -0.008   -0.013   -0.007    0.011 
   (0.032)   (0.032)   (0.032)   (0.032) 
Once to three times a month    0.0285    0.0175    0.0308    0.058 
   (0.0434)   (0.0433)   (0.0433)   (0.043) 
Hardly ever, or never    0.077**    0.063**    0.082***    0.234*** 
   (0.031)   (0.031)   (0.031)   (0.029) 
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Vigorous physical activity (ref: More than once a week)  
Once a week    0.001    0.005   -0.001   -0.0009 
   (0.038)   (0.038)   (0.038)   (0.038) 
Once to three times a month    0.041    0.040    0.038    0.040 
   (0.044)   (0.043)   (0.044)   (0.044) 
Hardly ever, or never    0.182***   0.183***    0.183***    0.233*** 
   (0.028)   (0.028)   (0.028)   (0.027) 
BMI (ref: normal weight)    
Undernourished   -0.210**   -0.210**   -0.203**   -0.138 
   (0.091)   (0.090)   (0.090)   (0.088) 
Overweight   -0.077*** -0.072***   -0.082***   -0.085*** 
   (0.023)   (0.023)   (0.023)   (0.023) 
Obese   -0.151*** -0.147***   -0.158***   -0.134*** 
   (0.029)   (0.029)   (0.029)   (0.029) 
Nursing home    0.203    0.201    0.207    0.329*** 
   (0.128)   (0.127)   (0.127)   (0.122) 
Chronic diseases    0.0189**   0.0205**    0.0156*    0.050*** 
   (0.009)   (0.009)   (0.009)   (0.008) 
Self-assessed health   -0.216*** -0.211***   -0.214***  
   (0.023)   (0.023)   (0.023)  
Number of difficulties in the 
IADLs 
  0.039***   0.037***    0.043***  
   (0.010)   (0.010)   (0.010)  
Number of difficulties in the 
ADLs 
   0.100***   0.100***    0.100***  
   (0.015)   (0.015)   (0.015)  
Years of education    0.001    0.002    0.002   -0.002 
   (0.003)   (0.002)   (0.002)   (0.002) 
Income/10 000   -0.003   -0.003   -0.003   -0.004 
   (0,004)   (0.004)   (0.004)   (0.005) 
Married    0.236***   0.242***    0.226***    0.214*** 
   (0.025)   (0.024)   (0.024)   (0.024) 
Retired    0.354***     0.302***    0.279*** 
   (0.029)    (0.028)   (0.028) 
L.sarcopeniamale    1.914***   1.942***    1.922***    1.942*** 
   (0.029)   (0.028)   (0.029)   (0.028) 
Constant   -2.316*** -4.945***   -4.881***   -3.628*** 
   (0.581)   (0.556)   (0.127)   (0.087) 
     
Observations 84 591 84 611 84 591 84 619 
Pseudo R2 0.3778 0.3734 0.3771 0.3684 
Country dummies YES YES YES YES 
Year dummies YES YES YES YES 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
Model (1) includes variables for age, age2 and for being retired. 
Model (2) excludes retired from the model.  
Model (3) excludes age2 from the model.  








Table VIII: Estimation Results from the Production Function with Different Specification for 
Women  
VARIABLES Model (1) Model (2) Model (3) Model (4) 
Age    0.055***    0.010    0.029***    0.031*** 
   (0.013)   (0.012)   (0.001)   (0.001) 
Age2   -0.0002**    0.0001   
 (8.79e-05)   (8.16e-05)  
Moderate physical activity (ref: More than once a week)  
Once a week    0.042*    0.044*    0.041*    0.062*** 
   (0.024)   (0.024)   (0.024)   (0.024) 
Once to three times a month    0.054     0.061*    0.053    0.092*** 
   (0.035)   (0.035)   (0.035)   (0.034) 
Hardly ever, or never    0.107***    0.115***    0.105***    0.236*** 
   (0.026)   (0.026)   (0.026)   (0.024) 
Vigorous physical activity (ref: More than once a week   
Once a week    0.117***    0.113***    0.118***    0.121*** 
   (0.029)   (0.029)   (0.029)   (0.029) 
Once to three times a month    0.0814**    0.0778**    0.0823**    0.088*** 
   (0.034)   (0.034)   (0.034)   (0.034) 
Hardly ever, or never    0.241***    0.238***    0.241***    0.293*** 
   (0.022)   (0.022)   (0.022)   (0.022) 
BMI (ref: normal weight)    
Undernourished    0.302***    0.296***    0.302***    0.339*** 
   (0.062)   (0.062)   (0.062)   (0.062) 
Overweight   -0.183***   -0.184***   -0.181***   -0.178*** 
   (0.019)   (0.019)   (0.019)   (0.019) 
Obese   -0.160***   -0.159***   -0.157***   -0.136*** 
   (0.022)   (0.022)   (0.022)   (0.022) 
Nursing home    0.343***    0.339***    0.342***    0.462*** 
   (0.111)   (0.112)   (0.112)   (0.110) 
Chronic diseases 0.0186***    0.0166**    0.0198***    0.054*** 
   (0.007)   (0.007)   (0.007)   (0.007) 
Self-assessed health   -0.254***   -0.252***   -0.254***   
   (0.019)   (0.019)   (0.019)  
Number of difficulties in the IADLs    0.061***    0.062***    0.059***  
   (0.009)   (0.009)   (0.009)  
Number of difficulties in the ADLs  0.0441***  0.0429***    0.0445***  
   (0.013)   (0.013)   (0.013)  
Years of education   -0.016***   -0.017***   -0.017***   -0.021*** 
   (0.002)   (0.002)   (0.002)   (0.002) 
Married   -0.218***   -0.220***   -0.215***   -0.217*** 
   (0.017)   (0.017)   (0.017)   (0.017) 
Income/10 000   -0.0002   -0.0004   -0.0003   -0.0008 
   (0.002)   (0.002)   (0.002)   (0.002) 
Retired   -0.218***    -0.204***   -0.209*** 
   (0.023)    (0.021)   (0.021) 
L.sarcopeniafemale    1.740***    1.753***    1.740***    1.774*** 
   (0.021)   (0.021)   (0.021)   (0.021) 
Constant   -4.248***   -2.669***   -3.369***   -3.628*** 
   (0.457)   (0.416)   (0.089)   (0.087) 
     
Observations 84 591 84 611 84 591 84 619 
Pseudo R2 0.3686 0.3664 0.3685 0.3608 
Country dummies YES YES YES YES 
Year dummies YES YES YES YES 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
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Model (1) includes variables for age, age2 and for being retired. 
Model (2) excludes retired from the model.  
Model (3) excludes age2 from the model.  
Model (4) excludes Number of difficulties in the IADLs and ADLS and self-assessed health  
 
 
